Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

COVID-19 vaccines are linked to menstrual changes in many women.

Oligomenorrhea is the strongest predictor of PCOS severity.

Gestational diabetes increases risks for mothers and babies, needing early diagnosis and care.

Some birth control pills have a higher risk of blood clots than others.

Rare ovarian tumors can cause increased male hormones in postmenopausal women; surgery is an effective treatment.

Different medications improved various PCOS symptoms and quality of life in Pakistani women, but did not significantly help with excessive hair growth.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Hair implants can cause infections, allergic reactions, itching, and scarring.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

Women with menstrual dysfunction often have deficiencies in magnesium, iron, and vitamin D.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Hormonal imbalances in women can cause acne, excess hair growth, and hair loss, needing combined medical and mental health care.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Early postmenopausal women often experience skin issues like vaginal dryness, swallowing difficulties, hair loss, and uncommonly, keratoderma and hirsutism, but many are unaware these are related to menopause.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Polymenorrhoea should be included in PCOS diagnostic criteria due to similar metabolic issues.

A rare ovarian tumor can cause unusual male-like symptoms, but surgery usually leads to a good outcome.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.